Maravai LifeSciences saw the highest growth of 3.99% in patent filings and 4.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 0.24%. GlobalData’s DataBook provides a comprehensive analysis of Maravai LifeSciences‘s patent filings and grants. Buy the databook here.
Maravai LifeSciences has been focused on protecting inventions in Spain(ES) with four publications in Q2 2024
The Spain(ES) Patent Office dominates the patent grants with nearly 50% of grants. The Hungary(HU), United States(US), European Patent Office(EPO), and Spain(ES) patent Office are among the top ten patent offices where Maravai LifeSciences is filings its patents. Among the top granted patent authorities, Maravai LifeSciences has 50% of its grants in Spain(ES), 38% in Poland(PL) and 12% in European Patent Office(EPO).
Roche could be the strongest competitor for Maravai LifeSciences
Patents related to health & wellness lead Maravai LifeSciences's portfolio
Maravai LifeSciences has the highest number of patents in health & wellness. For health & wellness, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Food related patents lead Maravai LifeSciences portfolio
Maravai LifeSciences has highest number of patents in food. For food, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of Maravai LifeSciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.